Defining Remission Using Patient‐reported Outcome Components of the Crohn's Disease Activity Index: Post‐hoc Analyses of Vedolizumab Data from the GEMINI 2 Study: 1865. (October 2015) - Sandborn, William J.; Vermeire, Séverine; Sands, Bruce E.; Feagan, Brian; Shetzline, Michael; Xu, Jing; Mody, Reema; Parikh, Asit; Abhyankar, Brihad